Table 1.
Treatment | FGF-2luciferase
|
RSVluciferase
|
||
---|---|---|---|---|
Low | High | Low | High | |
Control | 1.00 ± 0.15 | 0.054 ± 0.01 | 1.0 ± 0.15 | 0.5 ± 0.13 |
EGF | 2.79 ± 0.57a | 0.050 ± 0.006 | ||
FGF-2 | 2.70 ± 0.34a | 0.03 ± 0.006 | ||
PMA | 4.62 ± 1.20a | 0.08 ± 0.04 | 2.6 ± 0.04 | 1.1 ± 0.26 |
Astrocytes were transfected with (−650/+314)FGF-2luciferase or control RSVluciferase constructs as described in MATERIALS AND METHODS. After electroporation, cells were seeded into 12-well dishes at high (100% confluence) or low density (∼30% confluence). Attached cells were washed twice with PBS, and serum-free medium containing 0.25% BSA was added. Twenty-four hours later the cells were treated with EGF (5.0 × 10−9 M), 18-kDa FGF-2 (5 × 10−10 M), or PMA (100 nM) for an additional 24 h. The results are expressed relative to control luciferase activity in low-density cultures. Numbers for FGF-2luciferase represent mean ± SEM of 8–18 samples from two or three independent experiments. Three-way analysis of variance showed a significant interaction between growth factors or PMA and cell density (p < 0.002). Numbers for RSVluciferase from a single representative experiment and are shown for comparison.
Posthoc analysis: difference from control (p < 0.005).